Explore News
-
Obesity Drugs Boost Testosterone by 15%
Groundbreaking research on GLP-1 drugs and their impact on male fertility
-
Study Reveals Weight Loss Goals Boost GLP-1 Success
New research suggests setting a goal weight leads to better outcomes with GLP-1 drugs
-
AstraZeneca’s New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar
AstraZeneca’s elecoglipron shows promising results in phase 2 trial
-
AstraZeneca’s New Weight-Loss Pill Reveals Promising Trial Results
AstraZeneca’s new weight-loss pill has shown promising results in trials
-
Why Novo and Lilly are Racing for GLP-1 Supremacy
Novo Nordisk and Eli Lilly rivalry intensifies in GLP-1 pill market
-
Weight Loss Drugs Reduce Cancer Risk by 41%
New study reveals significant decrease in cancer risk for obese adults without diabetes using weight…
-
New Study Reveals Ozempic Resistance in 10% of Population
Groundbreaking research uncovers genetic variants affecting Ozempic efficacy
-
GLP-1s Like Ozempic May Help Lower Breast Cancer Risk. Here’s How
Research suggests GLP-1 drugs may serve as a breast cancer prevention strategy
-
GLP-1 Treatment Breaks New Ground in Addiction Prevention
New research reveals promising findings on GLP-1 drugs and their potential to combat addiction
-
Why Digital Platforms Matter for GLP-1 Access
New models of pharmaceutical access are emerging in the US
